EGFR and neoplasm: To examine whether a monovalent anti-TAA Fab was sufficient for targeting high density receptors on tumor cells, we generated anti-EGFR (clone GA201)/anti-CD3 (clone UCHT1) TED (hereafter EGFR TED) to test its cytotoxicity against the OVCAR3 cell line.